华法林联合低分子肝素钠治疗非大面积肺栓塞及呼吸困难的疗效探究
[摘要] 目的 探究华法林联合低分子肝素钠治疗非大面积肺栓塞及呼吸困难的临床疗效。 方法 方便选取该院2016年2月”2017年2月收治的74例非大面积肺栓塞及呼吸困难患者，将其平均分为对照组与观察组后分别采取单独低分子肝素钠与华法林联合低分子肝素钠治疗。观察并讨论两组各项临床指标及临床疗效情况。 结果 两组患者治疗前的各项临床指标情况，差异无统计学意义（P>0.05），而观察组患者使用联合治疗后，各项临床指标情况均优于对照组，差异有统计学意义（t=14.34、3.86、4.69、3.07；P=0.001、0.001、0.001、0.01）；观察组临床疗效情况优于对照组（97.30% vs 72.97%），差异有统计学意义（χ2=8.65；P=0.003）。结论 非大面积肺栓塞及呼吸困难应采用华法林联合低分子肝素钠进行治疗，可加快患者康复，具有更为理想的临床疗效。
[关键词] 非大面积肺栓塞；呼吸困难；华法林；低分子肝素钠
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742（2018）03（a）-0117-03
Effect of Warfarin Combined with Low Molecular Weight Heparin on Non-large-area Pulmonary Embolism and Dyspnea
XIE Li-na
Department of Respiratory Medicine， Zibo Mining Group Co.， Ltd. Central Hospital， Zibo， Shandong Province， 255120 China
[Abstract] Objective This paper tries to investigate the clinical effect of warfarin combined with low molecular weight heparin on non-large-area pulmonary embolism and dyspnea. Methods 74 cases of non large area pulmonary embolism and dyspnea patients from February 2016 to February 2017 were convenient selected and divided into control group and observation group. They were treated with low molecular weight heparin alone and warfarin combined with low molecular heparin sodium respectively. The clinical indexes and clinical efficacy of two groups were observed and discussed. Results The clinical indicators of two groups of patients before treatment， no significant difference（P>0.05）， while the observation group was treated with combina...
|
== 试读已结束，如需继续阅读敬请充值会员 ==
|
|
本站文章均为原创投稿，仅供下载参考，付费用户可查看完整且有格式内容！
(费用标准：38元/2月，98元/2年，微信支付秒开通！) |
| 升级为会员即可查阅全文 。如需要查阅全文，请 免费注册 或 登录会员 |
|
